JackHenryMD

Clinical Trials

• A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

  Completed

  Phase 2

• A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

  Completed

  Not Applicable

• A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides

  Completed

  Phase 3

• A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past

  Completed

  Phase 2

• The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

  Completed

  Phase 3

• The Treatment of Tuberculosis in HIV-Infected Patients

  Completed

  Phase 3

• Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. Start of enrollment: 2002 Sep 01

  Completed

  Phase 3

• Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01

  Completed

  Phase 3

• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Start of enrollment: 2006 Aug 01

  Completed

  Phase 3

• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation Start of enrollment: 2006 Dec 31

  Completed

  Phase 3

• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL Start of enrollment: 2007 Sep 01

  Withdrawn

  Phase 3

• Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III Start of enrollment: 2009 Jul 01

  Completed

  Phase 3

• Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13

  Completed

  Phase 3

• Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01

  Completed

  Phase 3

• Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23

  Active, not recruiting

  Phase 3

• Progesterone for the Treatment of Traumatic Brain Injury III Start of enrollment: 2010 Mar 01

  Terminated

  Phase 3

• Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2009 Aug 11

  Completed

  Phase 3

• Respiratory Virus Hospitalization Study (FLU 003 Plus) Start of enrollment: 2009 Aug 01

  Recruiting

• Respiratory Virus Outpatient Study (FLU 002 Plus) Start of enrollment: 2009 Aug 01

  Completed

• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Start of enrollment: 2010 Jul 01

  Completed

  Phase 3

• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01

  Active, not recruiting

  Phase 3

• Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2010 Sep 27

  Active, not recruiting

  Phase 3

• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Start of enrollment: 2010 Oct 01

  Completed

  Phase 3

• Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 May 25

  Active, not recruiting

  Phase 3

• Chondrofix Osteochondral Allograft Prospective Study Start of enrollment: 2011 Apr 01

  Terminated

  Not Applicable

• Join now to see all